Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02978638 · ClinicalTrials.gov registry record · NA

Electrical Stimulation for Continence After Spinal Cord Injury

A NA study of Spinal Cord Injury and Neurogenic Bladder, sponsored by Palo Alto Veterans Institute for Research.

Active
Registry status
NA
Development phase
10
Enrollment target
4
Study locations

NCT02978638: Active NA study of Spinal Cord Injury and Neurogenic Bladder, sponsored by Palo Alto Veterans Institute for Research.

NCT02978638 is a NA study of Spinal Cord Injury and Neurogenic Bladder that is active but no longer recruiting, run by Palo Alto Veterans Institute for Research. The registered enrollment target is 10 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (88% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02978638, a NA study of Spinal Cord Injury and Neurogenic Bladder, is active but no longer recruiting, sponsored by Palo Alto Veterans Institute for Research.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
4
Study locations

Study Summary

This study aims to improve continence and voiding of patients with spinal cord injury using electrical stimulation. The Finetech Vocare Bladder System is an implantable sacral nerve stimulator for improving bladder and bowel function in patients with spinal cord injury (SCI). It has been commercially available in Britain and other countries since 1982, and has been used in thousands of patients with SCI to improve bladder, bowel and sexual function. It received FDA approval in 1998 under Humanitarian Device Exemption H980005 and H980008 for providing urination on demand and to aid in bowel evacuation. Electrical stimulation to produce bladder contraction and improve bladder voiding after spinal cord injury has usually been combined with cutting of sensory nerves to reduce reflex contraction of the bladder, which improves continence. However, cutting these nerves has undesirable side effects. This study will not cut any sensory nerve. This study is testing the use of the stimulator for inhibiting bladder contraction by stimulating sensory nerves to improve continence after spinal cord injury, and for blocking sphincter contraction to improve voiding.

Primary Outcome

Bladder capacity (ml.) measured during filling cystometry

Interventions

  • DEVICE Finetech Vocare Bladder System

Study Locations (4)

California

  • Palo Alto Veterans Institute for Research - Palo Alto
  • Santa Clara Valley Medical Center - San Jose

New Mexico

  • University of New Mexico - Albuquerque

Ohio

  • MetroHealth Medical Center - Cleveland

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2014-09
Est. Completion 2025-09-28
Phase NA

What the registry record for NCT02978638 still lists

NCT02978638 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (88% lower).

The record links to 3 conditions, with Spinal Cord Injury appearing as the primary indexed condition, and to 1 intervention - of which Finetech Vocare Bladder System is the first listed.

NCT02978638 reports a single indexed study location in California, New Mexico, Ohio.

Frequently Asked Questions

What is clinical trial NCT02978638 about?

NCT02978638 is a clinical study titled "Electrical Stimulation for Continence After Spinal Cord Injury". This study aims to improve continence and voiding of patients with spinal cord injury using electrical stimulation. The Finetech Vocare Bladder System is an implantable sacral nerve stimulator for improving bladder and bowel function in patients with spinal cord injury (SCI). It has been commercial...

What is the current status of trial NCT02978638?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2014-09. Estimated completion is 2025-09-28.

What conditions does trial NCT02978638 study?

This clinical trial studies the following conditions: Spinal Cord Injury, Neurogenic Bladder, Incontinence.

What interventions are being tested in trial NCT02978638?

The interventions under investigation include: Finetech Vocare Bladder System (DEVICE).

Who is sponsoring clinical trial NCT02978638?

This trial is sponsored by Palo Alto Veterans Institute for Research, which has 35 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02978638 being conducted?

This trial has 4 study locations across California, New Mexico, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02978638's enrollment target sits among peer trials

10 82nd of 99 higher than 8 of 99 other Spinal Cord Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01870752 · 10 participants · NA

    Ovarian Tissue Transplantation

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02978638, the US trial registry maintained by the National Library of Medicine. NCT02978638 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.